The deal will give scientists at the Single Cell Genomics Centre access to Fluidigm's newest equipment and methods and will create new bioinformatics tools.
NEW YORK (GenomeWeb) — Fluidigm said after the close of the market on Thursday that its third quarter revenues increased 62 percent year over year, or 35 percent organically.
NEW YORK (GenomeWeb) – Fluidigm's second quarter revenues jumped 58 percent year over year, or 32 percent organically, the company reported after the close of the market on Thursday.
Fluidigm last week launched the C1 OpenApp Program, giving researchers the ability to create and share new single-cell applications on the C1 Single-Cell Auto Prep System.
NEW YORK (GenomeWeb) – Fluidigm continues to profit from sales of its C1 Single-Cell Auto Prep System. The company this week reported organic revenue growth of 58 percent, driven largely by sales of the C1 as well as the BioMark HD Systems bundled together with it.
NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market on Thursday a 33 percent increase in its fourth quarter revenues that included a 47 percent spike in consumables revenues.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
